Lowe’s Taps Creator Economy to Launch First Home Improvement Creator Network, With MrBeast Among the First to Join

PR Newswire

Launch includes MrBeast’s curated storefront on Lowes.com and exclusive partnership to build
the next iteration of BeastCity for “Beast Games” season two, blending creativity, community and
commerce.


MOORESVILLE, N.C.
, June 10, 2025 /PRNewswire/ — Lowe’s announces the launch of the first home improvement creator network, designed for creators who bring DIY skills to life through projects, spaces and community. Built to support creators of all sizes, the Lowe’s Creator Network helps creators share project-driven stories that build affinity for their own brands and for Lowe’s.

Among the first creators to join is MrBeast, the most-followed digital creator in the world, known for building massive audiences through inspiring content and his philanthropic efforts. Together, Lowe’s and MrBeast are curating a dedicated storefront where fans can shop his favorite materials, tools and DIY projects – from obstacle courses to backyard builds – bringing MrBeast’s signature creativity into homes across the country.

The Creator Network deepens Lowe’s connection with Millennial and Gen Z audiences, generations who turn to creators for inspiration, authenticity and trusted advice.

“Driving preference and engagement with the Lowe’s brand by tapping into creators with varying levels of followers is a key priority for Lowe’s as we look to gain relevance with younger generations while increasing digital engagement,” said Jen Wilson, chief marketing officer at Lowe’s. “We couldn’t be more excited to welcome MrBeast to our network along with other recognizable names like DadSocial and Chris Loves Julia. These are exciting names in the world of influencers and now they’ll be DIYing with Lowe’s across their social channels.”

Through its relationship with MrBeast, Lowe’s is now the exclusive building partner for season two of the highly anticipated series Beast Games. Staying true to its commitment to helpfulness, Lowe’s red vest associates are pitching in on the build of the latest BeastCity, a massive custom-designed complex that will house contestants and serve as the anchor set for the show. The building of BeastCity marks the first of many landmark projects between Lowe’s and MrBeast, with future content collaborations anticipated.

“We are always looking for strategic partnerships that will enhance the unique and exciting experiences our audiences are used to and this collaboration with Lowe’s Creator Network is exactly that”, said MrBeast CEO Jeff Housenbold. “We wanted to go even bigger and over-the-top with BeastCity in season two and we found the perfect partner to help us achieve that goal.”

The Lowe’s Creator Network features a multi-tiered system built to support creators at every stage of their journey. Through competitive commissions and customizable storefronts linked directly to Lowes.com, creators can start earning from their content right away. Members also gain access to product samples, training resources and a range of opportunities to help grow their businesses and connect with their audiences. As they advance within the network, creators unlock even greater value, including project funding, long-term sponsorships and exclusive access to events like the annual Lowe’s Creator Summit.

“Creators aren’t just making content. They’re building businesses by taking on real projects and connecting with their communities through meaningful storytelling,” said Jonathan Stanley, Lowe’s head of social and influencer marketing. “With Lowe’s Creator Network, we’re committed to helping our creators grow and are empowering them to bring their dream projects to life. From training resources to product samples and self-serve storefronts, we’re giving creators the resources to produce content they know their audiences will want to see.”

With more than 17,000 creators already enrolled during its beta launch, the Lowe’s Creator Network is poised for rapid growth, aiming to expand its presence across social feeds nationwide. The network builds visibility for not only Lowe’s but also for its vendor partners, with future plans to extend these opportunities through Lowe’s Retail Media Network, enhancing brand presence and community engagement across all digital channels.

The Lowe’s Creator Network is free to join. Creators can learn more and apply at Lowes.com/Creator.

About Lowe’s  
Lowe’s Companies, Inc. (NYSE: LOW) is a FORTUNE® 100 home improvement company serving approximately 16 million customer transactions a week in the United States. With total fiscal year 2024 sales of more than $83 billion, Lowe’s operates over 1,700 home improvement stores and employs approximately 300,000 associates. Based in Mooresville, N.C., Lowe’s supports the communities it serves through programs focused on creating safe, affordable housing, improving community spaces, helping to develop the next generation of skilled trade experts and providing disaster relief to communities in need. For more information, visit Lowes.com.

About MrBeast
MrBeast, founded by YouTube creator, entrepreneur, and philanthropist Jimmy Donaldson, is a global entertainment powerhouse known for its groundbreaking content, viral challenges, and large-scale philanthropic initiatives. With over 400 million subscribers, MrBeast became the most-subscribed YouTube channel in the world in June 2024 and now generates more than 2 billion views each month. His Prime Video series Beast Games became the streamer’s most-watched unscripted series ever and broke 44 Guinness World Records, further cementing his impact beyond digital platforms. Donaldson was named the #1 creator on Forbes’ 2023 Top Creators List and has been featured on both the TIME 100 and the inaugural TIME 100 Climate list. In 2022, he launched Feastables, a snack brand that quickly became one of the fastest-growing CPG companies in history. A leader in digital-first philanthropy, Donaldson has spearheaded major global campaigns, including #TeamTrees, which raised over $23 million to plant 23 million trees, and #TeamSeas, which removed 30 million pounds of waste from oceans, rivers, and beaches. In 2020, he founded Beast Philanthropy, a 501(c)(3) nonprofit that has since provided more than 20 million meals and funded critical infrastructure projects for underserved communities around the world.

Contact:  
Amanda Caskey
Lowe’s Companies, Inc.
[email protected] 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/lowes-taps-creator-economy-to-launch-first-home-improvement-creator-network-with-mrbeast-among-the-first-to-join-302477293.html

SOURCE Lowe’s Companies, Inc.

IBM Study: Businesses View AI Agents as Essential, Not Just Experimental

PR Newswire

  • Surveyed executives report anticipated 8x surge in AI-enabled workflows by 2025, with AI agents improving process efficiency, reducing costs, and changing workflows. 
  • Respondents say that 64% of AI budgets are now spent on core business functions.
  • Over two-thirds (69%) of executives surveyed say ‘improved decision-making’ is the number one benefit of agentic AI systems.


ARMONK, N.Y.
, June 10, 2025 /PRNewswire/ — A new study by the IBM (NYSE: IBM) Institute for Business Value reveals that enterprises are expected to significantly scale AI-enabled workflows, many driven by agentic AI, relying on them for improved decision making and automation.

The AI Projects to Profits study, which surveyed 2,900 executives globally, revealed that respondents expect AI-enabled workflows to grow from 3% today to 25% by the end of 2025. With 70% of surveyed executives indicating that agentic AI is important to their organization’s future, the research suggests that many organizations are actively encouraging experimentation. 

As the pace of digital transformation accelerates, enterprises can turn to AI agents as the next evolution of intelligent automation. 83% of respondents say they expect AI agents to improve process efficiency and output by 2026, and 71% believe agents will autonomously adapt to changing workflows.

“We see more clients looking at agentic AI as the key to help them move past incremental productivity gains and actually gain business value from AI, especially when applied in their core processes like supply chain and HR,” said Francesco Brenna, VP & Senior Partner, AI Integration Services, IBM Consulting. “This isn’t about plugging an agent into an existing process and hoping for the best. It means re-architecting how the process is executed, redesigning the user experience, orchestrating agents end-to-end, and integrating the right data to provide context, memory, and intelligence throughout.” 

These are the top five benefits of agentic AI systems that are driving adoption across industries, according to the report: 

  1. Over two-thirds (69%) of executives surveyed say ‘improved decision-making’ is the number one benefit of agentic AI systems.
  2. 67% of those surveyed cite ‘cost reduction through automation’ as a benefit.
  3. Almost half (47%) of leaders surveyed indicate ‘competitive advantage’ as a top benefit of agentic AI systems.
  4. ‘Scaled employee experience’ is cited as a top benefit, according to 44% of executives surveyed. 
  5. 42% of those surveyed indicate that ‘improved talent retention’ is another major benefit to implementing agentic AI systems.

Though benefits were cited among those surveyed, concerns with agentic AI adoption are still present among leaders. Those surveyed indicate that concerns around data (49%), trust issues (46%) and skills shortages (42%) remain barriers to adoption for their organizations. 

Other key findings include: 

  • Executives surveyed indicate that AI investment has grown to about 12% of IT spend in 2024. By 2026, the participants indicated they expect this number is to increase by over two-thirds to account for 20% of IT spend.
  • Respondents say that 64% of AI budgets are now spent on core business functions, underscoring AI’s move from an experimentation phase to an important part of business strategy.
  • The proportion of surveyed organizations relying on an ad hoc approach to AI has declined from a reported 19% last year to just 6% today, indicating increased confidence and commitment to AI-driven transformation.
  • One in four companies surveyed are already using an “AI-first” approach
    • Among those with an “AI-first” approach, respondents say they attribute more than half of their revenue growth (52%) and operating margin improvements (54%) to AI initiatives in the last 12 months

To view the full study, visit https://www.ibm.com/thought-leadership/institute-business-value/en-us/report/agentic-ai-profits

Study Methodology:
The IBM Institute for Business Value study, in partnership with Oxford Economics, draws insights from two 2025 surveys: the “AI at the core survey” (2,500 executives across 18 industries and 19 regions) and the “Agentic AI pulse survey” (400 C-suite executives across 15 roles, 11 industries, and 6 countries). Survey questions explored AI’s current role in business operations, including its impact on revenue, profitability, productivity, and resource efficiency. Further analysis was conducted to identify key relationships, trends and associations within the dataset. 

The IBM Institute for Business Value, IBM’s thought leadership think tank, combines global research and performance data with expertise from industry thinkers and leading academics to deliver insights that make business leaders smarter. For more world-class thought leadership, visit: www.ibm.com/ibv. To receive more insights, subscribe to the IdeaWatch newsletter: https://ibm.co/ibv-ideawatch.

About IBM

IBM is a leading provider of global hybrid cloud and AI, and consulting expertise. We help clients in more than 175 countries capitalize on insights from their data, streamline business processes, reduce costs and gain the competitive edge in their industries. Thousands of government and corporate entities in critical infrastructure areas such as financial services, telecommunications and healthcare rely on IBM’s hybrid cloud platform and Red Hat OpenShift to affect their digital transformations quickly, efficiently and securely. IBM’s breakthrough innovations in AI, quantum computing, industry-specific cloud solutions and consulting deliver open and flexible options to our clients. All of this is backed by IBM’s long-standing commitment to trust, transparency, responsibility, inclusivity and service. Visit www.ibm.com for more information. 

Media Contact: 

Marisa Conway

IBM Corporate Communications
[email protected] 

Kristen Shah

IBM Consulting Communications
[email protected]

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/ibm-study-businesses-view-ai-agents-as-essential-not-just-experimental-302476922.html

SOURCE IBM

SEI Research Finds 43 Percent of Private Markets Staff Consumed by Fund Admin Replication

PR Newswire

High Replication, Multi-Administrator Model Contributes to Increased Costs and Inefficiencies


OAKS, Pa. and LONDON
, June 10, 2025 /PRNewswire/ — SEI® (NASDAQ: SEIC) today unveiled research that found private market asset managers identify data replication and fragmentation from multiple fund administrators as a challenge, causing operational inefficiencies, resource drain, and increased costs. Conducted in partnership with Cutter Associates, the survey examined the private market fund administration landscape and the current and target state replication model through feedback from U.S.- and U.K.-based managers.


Phil McCabe, Head of SEI’s Investment Managers business, commented on the industry landscape:

“Global private markets assets under management have grown nearly 20% annually since 20181. As firms scale to meet demand, they can find themselves working with multiple fund administrators—whether that’s driven by regulatory pressures, cross-border operations, or M&A activity over time. Managing data replication in house through technology and staffing can be a drain on resources, but a modern fund administrator can serve as a primary strategic partner in managing multiple asset classes and domiciles, while consolidating data.”

KEY HIGHLIGHTS

  • Outsourcing is widespread, but so is replication. Many firms duplicate their administrators’ work in-house, with 55% keeping an internal accounting book of record, and 43% saying more than half of their non-investment staff are involved in oversight or replication.

  • Replication costs are high, and those costs aren’t only financial. One-third of firms are concerned about technology costs, and replication delays reporting (47% say by three or more days) and threatens data visibility. But many firms feel compelled to maintain the status quo due to risk concerns or investments already made in internal systems.

  • The fewer fund administrators, the better. While the majority of firms (57%) work with multiple administrators—more than seven in some cases, 58% indicated one provider as their ideal number, and 21% would like just two providers.

  • The replication model is shifting. One-quarter (24%) of firms are actively reducing replication, and another 55% say they would consider it as part of future strategic plans. Nearly two-thirds (62%) say the ability to reduce replication influences their choice of fund administrator.

Commenting on the research, Bryan Astheimer, Head of SEI’s Investment Managers business for EMEA, said:

“The increasingly complex environment is putting pressure on firms to meet investor demand while maintaining operational efficiency and improving the bottom line. A single strategic partner that offers data quality, multi-domicile capabilities, and seamless system integrations makes a strong case for consolidating fund administrators. But firms don’t need to tackle everything overnight in an ever-evolving landscape. A first step in the right direction can begin with one product launch, taking a phased approach to a journey of transformation.”

Methodology

The research is based on a proprietary survey conducted by Cutter Associates of senior decision-makers at private markets firms headquartered in North America, the U.K., and Europe, each with at least $2 billion in assets under management.

The surveyed firms span a range of asset classes, including private equity, private debt, real estate, infrastructure, and hedge funds. The research was conducted at the end of 2024.

1
McKinsey & Company, “Global Private Markets Report 2024: Private markets in a slower era,” March 28, 2024.

About SEI®
SEI (NASDAQ:SEIC) is a leading global provider of financial technology, operations, and asset management services within the financial services industry. SEI tailors its solutions and services to help clients more effectively deploy their capital—whether that’s money, time, or talent—so they can better serve their clients and achieve their growth objectives. As of March 31, 2025, SEI manages, advises, or administers approximately $1.6 trillion in assets. For more information, visit seic.com.

About SEI’s Investment Managers business
SEI’s Investment Managers business provides advanced operating infrastructure for investment organizations of all types to evolve and compete in a landscape of escalating business challenges. SEI’s global operating platform delivers customized and integrated capabilities across a wide range of investment vehicles, strategies, and jurisdictions to investment managers and asset owners. The company’s services enable users to gain scale and efficiency, keep pace with marketplace demands, and run their businesses more strategically. As of March 31, 2025, SEI partners with more than 315 traditional asset managers, alternative managers, and sovereign wealth managers, including 43 of the top 100 asset managers worldwide.* For more information, visit seic.com/ims.

*Based on Pensions & Investments’ “Largest Money Managers” 2023 ranking.

About Cutter Associates
Cutter Associates LLC serves the operational, technology, and client experience needs of the global asset and wealth management industry, providing companies with the tools and services they need to be successful. With deep industry and domain experience and expertise, Cutter Associates provides global consulting, independent research, exclusive members-only events, process benchmarking, and a vast peer network. Headquartered in Rockland, Massachusetts, and owned by Tokyo-based NRI Group, Cutter Associates offers services in the United States, Canada, Australia, United Kingdom, European Union, Singapore, and Asia. For more information, visit us www.cutterassociates.com and connect on LinkedIn.

Important information
Information provided by SEI Investment Managers business; SEI Investments Global Fund Services Limited; SEI Investments–Depositary and Custodial Services (Ireland) Limited; SEI Investments– Luxembourg S.A.; and SEI Investments (Europe) Limited, which are wholly owned subsidiaries of SEI Investments Company. The Investment Managers business is an internal business unit of SEI Investments Company.



Company Contact:
 




Media Contact:


Leslie Wojcik

Amelia Graham

SEI

Vested

+1 610-676-4191

+44 (0)7393 477 057


[email protected]


[email protected] 

Eric Hazard

Vested


[email protected]

+1 214 734 8203

Cision View original content:https://www.prnewswire.com/news-releases/sei-research-finds-43-percent-of-private-markets-staff-consumed-by-fund-admin-replication-302476715.html

SOURCE SEI Investments Company

U Power Provides Business Update and Outlines Key Objectives for 2025 and Beyond

PR Newswire


Investing in Next-Generation Technologies with a Goal of Becoming a Smart Energy Grid Solutions Provider


SHANGHAI
, June 10, 2025 /PRNewswire/ — U Power Limited (Nasdaq: UCAR) (the “Company” or “U Power”), a provider of comprehensive electric vehicle (“EV”) battery-swapping solutions with a vision of becoming a smart energy grid solutions provider, today provides an update of recent business developments, strategic partnerships and outlines its key growth initiatives for 2025 and beyond.


Recent Business Developments
 

Expanded our client base and domestic footprint: Our proprietary UOTTA-powered battery-swapping stations and related solutions continued to gain traction. Our UOTTA technology offers fast, efficient battery swap for a variety of EVs including commercial trucks, buses, light trucks and passenger vehicles, including two wheeled and three wheeled.  For full year 2024 we reported total revenue of $6.2 million, representing an increase of 124% as compared to full year 2023. During 2024 we sold and delivered a total of 12 battery-swapping stations.

Established global partnerships: We have established various partnerships in Thailand, Portugal, Hong Kong, Peru and Mexico to jointly promote UOTTA battery-swapping services and we are working on building a battery-swapping ecosystem in these markets. We are partnering with major EV manufacturers in these markets to facilitate the sales of UOTTA-powered EVs and have begun delivering battery-swapping stations initially for taxi and ride-hailing services.

Patents: We continued to strengthen our capabilities and introduced innovative UOTTA solutions supported by a large number of patents (46 issued patents and 18 pending patent applications).

Two-Fold Growth Strategy for 2025 and Beyond

Our key objective is to continue to grow our existing business, establish new business lines and generate additional revenue streams via a well-thought business plan based on two main pillars.

1.      Leverage existing battery-swapping technology to build a comprehensive UOTTA-centered ecosystem. Specifically, we are:

  • Incorporating UOTTA into more EVs in our local market by taking advantage of the widespread adoption of EVs.
  • Accelerate international rollout via several partnerships we have established in Southeast Asia, Southern Europe and South America, and new ones we are targeting.
  • Continue investing in technology innovation and continuous upgrades of our one-stop UOTTA solutions.

2.      Invest in next-generation technologies to develop comprehensive solutions for EV manufactures and drivers, aiming to transform EVs into dynamic assets for smart energy grids. Specifically, we plan to:

  • Continue investing in our AI-based data management cloud platform which connects UOTTA-powered EVs with stations and assists UOTTA-powered EV drivers locate the closest compatible UOTTA swapping stations on their route. Our continued investment aims to develop a comprehensive battery power solution platform which will offer advanced real-time data connections, analysis and forecasting capabilities, improve driving and re-charging experience, and serve as a complete urban road transportation solution.
  • Introduce “Battery Bank” solutions into the platform, aiming to enhance the performance of battery life cycle and use AI blockchain technology to monetize battery assets.
  • Introduce “Commercial Energy Storage” solutions for distributed and/or centralized energy storage stations, industrial and commercial EV charging and swapping stations, etc.

Johnny Lee, CEO and Chairman of U Power commented, “In early 2024 we made the strategic decision to re-organize and transform our business into a comprehensive solution provider for EVs, with a goal of becoming a smart energy grid solutions provider. The first step towards reaching our goal was the development of UOTTA battery-swapping stations and related solutions which reduce cost and timing of EV charging. Also, our UOTTA solutions are designed to minimize the need for extensive EV charging grid upgrades and facilitate the establishment of efficient and sustainable charging networks for the growing EV fleets of passenger cars or commercial trucks, which we are offering to both domestic and international customers. Our next step is to create a mature ecosystem by scaling up our UOTTA battery swapping operations, which will eventually enable and accelerate the development and implementation of new AI-based data management offerings and services such as Battery Bank business solutions, and Commercial Energy Storage solutions, transforming EVs into dynamic assets for smart energy grids.”

Mr. Lee added, “We believe our two-fold strategy has well-positioned U Power to grow revenue from existing business lines, create new revenue streams, improve profitability, expand client base and geographic footprint and ultimately create value for shareholders.”

About U Power Limited

U Power is a comprehensive provider of electric vehicle (EV) battery swapping solutions using its proprietary modular battery-swapping technology, UOTTA™. U Power manufactures and sells different models of UOTTA battery-swapping stations for EVs, and sells and rents battery swap cabinets to two-wheeled vehicle drivers. U Power also provides battery-swapping services for vehicle drivers and station control system upgrading services for battery-swapping station owners.

Through investments in next-generation technologies, U Power’s vision is to become a comprehensive solutions provider for smart energy grids. Expanding on its UOTTA technology platform, the Company is investing in building intelligent ecosystems that integrate resilient AI driven solutions able to transform electric vehicles (EVs) into dynamic energy assets.

For more information, please visit the Company’s website: https://www.upower-limited.com/.

Safe Harbor Statements

This press release contains “forward-looking statements”. Forward-looking statements reflect our current view about future events. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can identify these forward-looking statements by words or phrases such as “may,” “will,” “could,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “is/are likely to,” “propose,” “potential,” “continue” or similar expressions. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results, and encourages investors to review other factors that may affect its future results in the Company’s registration statements and other filings with the U.S. Securities and Exchange Commission. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. References and links (including QR codes) to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release.

Contact 

U Power Limited 
Investor Relations Department
[email protected]

The Equity Group

Lena Cati, Senior Vice President
212-836-9611 / [email protected] 

Alice Zhang, Associate
212-836-9610 / [email protected]  

 

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/u-power-provides-business-update-and-outlines-key-objectives-for-2025-and-beyond-302476571.html

SOURCE U Power Limited

KITCHENAID RELEASES NEW PURE POWER BLENDER GIVING CONSUMERS THE CONTROL AND CONFIDENCE TO BLEND THE RULES

PR Newswire

Discover an Exciting World of Blending for Hot or Cold Recipes Across a Wide Range of Textures


BENTON HARBOR, Mich.
, June 10, 2025 /PRNewswire/ — Today, KitchenAid introduces its latest innovation, the KitchenAid® Pure Power Blender, giving consumers the freedom to blend the rules. The blender’s precision speed control knob, 360 asymmetrical blade design, and heat release vent gives consumers the confidence and control in making their favorite recipes just the way they like them.

“Equipped to handle hot or cold foods, the KitchenAid® Pure Power Blender gives consumers the control they need to create their favorite recipes their way,” said Chad Ries, Global Brand Marketing Director at KitchenAid Small Appliances. “Whether creating a creamier smoothie or a chunkier salsa, KitchenAid is excited to give people the power to take control of their favorite recipes with a simple twist of a knob.”

In addition to its powerful performance and precision speed control, the KitchenAid® Pure Power Blender also features a fitted vented lid that allows steam to escape while blending hot ingredients. The KitchenAid® Pure Power Blender has been awarded the Red Dot Award: Product Design 2025 by an international jury for its outstanding and high quality design.

The new countertop appliance comes with three presets including Ice Crush to turn ice to snow in seconds, Smoothie Cycle to take on the toughest ingredients from the freezer with ease, and Clean Cycle, giving the consumers the opportunity to quickly use their desired setting with the push of a button.

Additional key features of the KitchenAid® Pure Power Blender:

  • Precision Speed Control Knob: Take control of your blends with an asymmetric blade design and variable speed for a wide range of desired textures.
  • Precision Speed Control Knob + Pulse: From chunky salsa to smooth tomato soup, the precision speed control knob helps you achieve the blends you want. Choose your exact setting between 1 and 10 or smoothly glide between the speeds to create your desired texture.
  • Texture Control: Whether it’s roasted tomatoes fresh from the oven or frozen foods straight from the freezer, blend foods into a whole range of textures for your hot or cold recipes.
  • Powerful Ice Crushing Blades: From ice to snow in seconds, powerful 360 asymmetrical blades blend at different angles, pulling ice to the center and breaking down the toughest ingredients.
  • Smoothie Cycle: Turn your favorite ingredients from the freezer into smoothies with ease at the push of a button.

The KitchenAid® Pure Power Blender in Black Matte is now available for purchase on KitchenAid.com with additional colors launching in July:

  • KitchenAid® PurePower Blender
    • KSB2072BM– MSRP1$129.99

About KitchenAid
Since the introduction of its legendary stand mixer in 1919 and first dishwasher in 1949, KitchenAid has built on the legacy of these icons to create a complete line of products designed for those with a passion to make. Today, the KitchenAid® brand offers virtually every essential for the well-equipped kitchen with a collection that includes everything from countertop appliances to cookware, ranges to refrigerators, and whisks to wine cellars. To learn more, visit KitchenAid.com or follow us on Instagram, @KitchenAidUSA.

About Whirlpool Corporation
Whirlpool Corporation (NYSE: WHR) is a leading home appliance company, in constant pursuit of improving life at home. As the last-remaining major U.S.-based manufacturer of kitchen and laundry appliances, the company is driving meaningful innovation to meet the evolving needs of consumers through its iconic brand portfolio, including Whirlpool, KitchenAid, JennAir, Maytag, Amana, Brastemp, Consul, and InSinkErator. In 2024, the company reported approximately $17 billion in annual sales – close to 90% of which were in the Americas – 44,000 employees, and 40 manufacturing and technology research centers. Additional information about the company can be found at WhirlpoolCorp.com.

Media Contact:
MSL
[email protected]


1
 MSRP is manufacturer’s suggested retail price. Dealer alone determines actual retail and advertised prices.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/kitchenaid-releases-new-pure-power-blender-giving-consumers-the-control-and-confidence-to-blend-the-rules-302473880.html

SOURCE KitchenAid

Corteva to Participate in Wolfe’s Materials of the Future Conference

PR Newswire


INDIANAPOLIS
, June 10, 2025 /PRNewswire/ — Corteva, Inc. (NYSE: CTVA) announces that Chief Executive Officer, Chuck Magro, and Executive Vice President and Chief Financial Officer, David Johnson, will speak at Wolfe’s second annual Materials of the Future conference at 12:20 p.m. Eastern Time on Tuesday, June 17, 2025.

Remarks will be webcast live. The webcast can be accessed through the Corteva Investor Relations website. A replay of the presentation will be available within 24 hours after the presentation ends and will be accessible until September 17, 2025.

About Corteva
Corteva, Inc. (NYSE: CTVA) is a global pure-play agriculture company that combines industry-leading innovation, high-touch customer engagement and operational execution to profitably deliver solutions for the world’s most pressing agriculture challenges. Corteva generates advantaged market preference through its unique distribution strategy, together with its balanced and globally diverse mix of seed, crop protection, and digital products and services. With some of the most recognized brands in agriculture and a technology pipeline well positioned to drive growth, the Company is committed to maximizing productivity for farmers, while working with stakeholders throughout the food system as it fulfills its promise to enrich the lives of those who produce and those who consume, ensuring progress for generations to come. More information can be found at www.corteva.com.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/corteva-to-participate-in-wolfes-materials-of-the-future-conference-302474607.html

SOURCE Corteva Agriscience

Innoviz Technologies Launches InnovizSMART, Bringing Automotive-Grade LiDAR Performance to Security, Mobility, Aerial, Robotics & Intelligent Traffic Management Applications

PR Newswire

InnovizSMART Long-Range delivers outstanding 3D performance, resolution, range, and reliability for security, urban mobility, aerial, robotics and intelligent traffic deployments


TEL AVIV, Israel
, June 10, 2025 /PRNewswire/ — Innoviz Technologies Ltd. (Nasdaq: INVZ) (the “Company” or “Innoviz”), a leading Tier-1 direct supplier of high-performance, automotive-grade LiDAR sensors and perception software, announced today the launch of InnovizSMART Long-Range, a new high-performance LiDAR sensor tailored for smart applications, such as security, mobility, aerial, robotics, and intelligent traffic management. The product brings Innoviz’s proven automotive-grade performance to the smart applications space, offering a long-range solution with native Power over Ethernet (PoE) support for easy deployment and maintenance in urban environments.

Developed further to demand from customers, InnovizSMART is a rugged and reliable LiDAR sensor that features low-power consumption, a uniform field-of view and high-resolution 3D point cloud that enables accurate object detection at distances of up to 400 meters – even in harsh outdoor conditions like dust, sunlight, and rain. With PoE capabilities, the system requires only a single Ethernet cable for both data and power, simplifying installation and reducing infrastructure costs.

InnovizSMART Key features include:

  • True long-range detection of up to 400 meters, with accurate identification of pedestrians and vehicles even at extended distances.
  • Blockage resilience to dust, debris, and extreme temperatures.
  • Uniform resolution across the field of view, enabling consistent tracking performance across wide intersections or corridors.
  • PoE-enabled connectivity, allowing for fast deployment on existing poles or traffic light infrastructure using standard Ethernet.
  • Privacy-conscious by design: InnovizSMART captures spatial data without identifying personal characteristics, offering cities a reliable tool for improving safety and efficiency while upholding privacy standards.

“InnovizSMART is built on the same technological foundation as Innoviz automotive solutions, bringing the quality and standard to the smart infrastructure space,” said Omer Keilaf, CEO and Co-Founder of Innoviz. “From traffic optimization to security deployments and more, InnovizSMART offers cities and solution providers a high-performance tool with the privacy, reliability, and durability of an automotive-grade product.”

For more information about InnovizSMART Long-Range, email: [email protected].

About Innoviz

Innoviz is a global leader in LiDAR technology, serving as a Tier-1 supplier to the world’s leading automotive manufacturers and working towards a future with safe autonomous vehicles on the world’s roads. Innoviz’s LiDAR and perception software “see” better than a human driver and reduce the possibility of error, meeting the automotive industry’s strictest expectations for performance and safety. Operating across the U.S., Europe, and Asia, Innoviz has been selected by internationally recognized premium car brands for use in consumer vehicles as well as by other commercial and industrial leaders for a wide range of use cases. For more information, visit innoviz.tech.com.

Join the discussion: Facebook, LinkedIn, YouTube, Twitter 

Media Contact

[email protected] 

Investor Contact 

[email protected]            


Forward Looking Statements
 

This announcement contains certain forward-looking statements within the meaning of the federal securities laws, including statements regarding the services offered by Innoviz, the anticipated technological capability of Innoviz’s products, the markets in which Innoviz operates and Innoviz’s projected future operational and financial results. These forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. 

Many factors could cause actual future events to differ materially from the forward-looking statements in this announcement including but not limited to, the ability to implement business plans, forecasts, and other expectations, the ability to convert design wins into definitive orders and the magnitude of such orders, the ability to identify and realize additional opportunities, potential changes and developments in the highly competitive LiDAR technology and related industries, and our expectations regarding the impact of the evolving conflict in Israel to our ongoing operations. The foregoing list is not exhaustive. You should carefully consider such risk and the other risks and uncertainties described in Innoviz’s annual report on Form 20-F for the year ended December 31, 2024, filed with the U.S. Securities and Exchange Commission (“SEC”) on March 12, 2025 and in other documents filed by Innoviz from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and Innoviz assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. Innoviz gives no assurance that it will achieve its expectations.

Photo: https://mma.prnewswire.com/media/2707318/Innoviz_Technologies.jpg
Logo:  https://mma.prnewswire.com/media/1496323/Innoviz_Technologies_Logo.jpg

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/innoviz-technologies-launches-innovizsmart-bringing-automotive-grade-lidar-performance-to-security-mobility-aerial-robotics–intelligent-traffic-management-applications-302477531.html

SOURCE Innoviz Technologies

Comerica Announces Full Redemption of its Series A Preferred Stock and Related Depositary Shares

PR Newswire


DALLAS
, June 10, 2025 /PRNewswire/ — Comerica Incorporated (NYSE: CMA) announced today that it will redeem all 4,000 outstanding shares of its 5.625% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock, Series A (the “Preferred Stock”), and the corresponding depositary shares, each representing a 1/100th ownership interest in a share of Preferred Stock (the “Depositary Shares”).

The Depositary Shares will be redeemed simultaneously with the Preferred Stock on the upcoming dividend payment date on July 1, 2025 (the “Redemption Date”), at a redemption price of $1,000 per Depositary Share (equivalent to $100,000 per share of Preferred Stock) (the “Redemption Price”). Accordingly, the Redemption Price does not include declared and unpaid dividends. Regular quarterly dividends will be paid separately in the customary manner on July 1, 2025, to holders of record at the close of business on June 13, 2025, prior to the consummation of the redemption.

All regulatory requirements relating to the redemption of the Preferred Stock and corresponding Depositary Shares have been satisfied by Comerica. The Depositary Shares are held through The Depository Trust Company (“DTC”) and will be redeemed in accordance with the applicable procedures of DTC. Payment of the Redemption Price for the Depositary Shares will be made to DTC by Computershare Inc. and Computershare Trust Company, N.A., jointly, as redemption agent, on the Redemption Date. The address for the redemption agent is:

Computershare Trust Company, N.A.
Attn: Corporate Actions, COY: CMA
150 Royall Street, Suite 101
Canton, MA 02021.

Investors in the Depositary Shares should contact the bank or broker through which they hold a beneficial interest in the Depositary Shares for information about obtaining the redemption payment for the Depositary Shares in which they have a beneficial interest.

This press release does not constitute a notice of redemption under the certificate of designations governing the Preferred Stock or the deposit agreement governing the Depositary Shares.

Comerica Incorporated (NYSE: CMA) is a financial services company headquartered in Dallas, Texas, and strategically aligned by three business segments: The Commercial Bank, The Retail Bank and Wealth Management. Comerica, one of the 25 largest commercial U.S. financial holding companies, focuses on building relationships and helping people and businesses be successful. Comerica provides banking centers across the country with locations in Arizona, California, Florida, Michigan and Texas. Founded on Aug. 17, 1849, in Detroit, Michigan, Comerica continues to expand into new regions, including its Southeast Market, based in North Carolina, and Mountain West Market in Colorado. Comerica has offices in 15 states and services 13 of the 15 largest U.S. metropolitan areas, as well as Canada and Mexico. Comerica reported total assets of $77.6 billion at March 31, 2025. Learn more about how Comerica is raising expectations of what a bank can be by visiting www.comerica.com, and follow us on Facebook, X, Instagram and LinkedIn.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/comerica-announces-full-redemption-of-its-series-a-preferred-stock-and-related-depositary-shares-302477665.html

SOURCE Comerica Incorporated

MBX Biosciences to Present at the American Diabetes Association 85th Scientific Sessions

CARMEL, Ind., June 10, 2025 (GLOBE NEWSWIRE) — MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders, today announced presentations at the American Diabetes Association’s (ADA) 85th Scientific Sessions, taking place June 20-23. 2025, Chicago, IL.

  • 846-P – Safety, Pharmacokinetics, and Pharmacodynamics of MBX 1416, a Glucagon-Like Peptide-1 Receptor Antagonist, in Healthy Volunteers: A Phase 1 Randomized Trial

    Presenter: Elisa Fabbrini, MD. PhD.
    Session: General Poster Session
    Date: Sunday June 22nd, 2025
    Time 12:30-1:30pm CT
  • 845-P – MBX 1416, a Selective GLP-1 Antagonist, Elevates and Sustains Blood Glucose in Rats without Change in Body Weight

    Presenter: Richard DiMarchi, PhD.
    Session: General Poster Session
    Date: Sunday June 22nd, 2025
    Time: 12:30-1:30pm CT

The findings presented in the posters demonstrate the mechanism of action of MBX 1416 and illustrate its potential benefits as a once-weekly treatment for post-bariatric hypoglycemia (PBH). MBX announced earlier this year that MBX 1416 demonstrated positive topline results in a Phase 1 single ascending dose (SAD) and multiple ascending dose (MAD) clinical trial in healthy adult volunteers. A Phase 2 trial is expected to be initiated in the second half of 2025.

Following congress publication, the presentations will be available for review on MBX Biosciences publications page https://investors.mbxbio.com/news-events/presentations.

About MBX 1416

MBX 1416 is an investigational long-acting glucagon-like peptide-1 (GLP-1) receptor antagonist in development as a potential treatment for PBH. It was designed using the Company’s novel, proprietary PEP™ platform to prevent the occurrence of severe hypoglycemia in individuals with PBH so they can lead healthier and more independent lives.

About Post-bariatric Hypoglycemia

Post-bariatric hypoglycemia (PBH) is a rare and serious complication of bariatric surgery. PBH is characterized by repeated episodes of symptomatic hypoglycemia, triggered by exaggerated secretion of GLP-1 levels following a meal, and can present as early as six months after Roux-en-Y gastric bypass or sleeve gastrectomy. Hypoglycemic episodes can occur multiple times per day and can periodically manifest with severe symptoms, such as dizziness, confusion, loss of consciousness or seizure. The unpredictability of hypoglycemic episodes and their associated risks may meaningfully hinder daily activities. As a result, the patient burden can be substantial, and many individuals cannot drive, work, or live alone. To date, there are no approved pharmacotherapies to treat PBH. As the use of surgery to address metabolic conditions continues to rise, the incidence of PBH is expected to increase, reinforcing the need for safe and effective therapies.

About MBX Biosciences 

MBX Biosciences is a biopharmaceutical company focused on the discovery and development of novel precision peptide therapies based on its proprietary PEP™ platform, for the treatment of endocrine and metabolic disorders. The Company is advancing a pipeline of novel candidates for endocrine and metabolic disorders with clinically validated targets, established endpoints for regulatory approval, significant unmet medical needs and large potential market opportunities. The Company’s pipeline includes canvuparatide (MBX 2109) for the treatment of chronic hypoparathyroidism (HP) in Phase 2 development; MBX 1416 for the treatment of post-bariatric hypoglycemia (PBH) in Phase 1 development; and an obesity portfolio that includes MBX 4291, with an IND filing anticipated in Q2 2025, as well as multiple discovery and pre-clinical obesity candidates. The Company is based in Carmel, Indiana. To learn more, please visit the Company website at https://mbxbio.com/ and follow it on LinkedIn.

Media Contact:

Kati Beach Oltsik
Inizio Evoke Comms
[email protected]   
(937) 232-4889

Investor Contact:

Jim DeNike
MBX Biosciences
[email protected]



X4 Pharmaceuticals Granted Fast Track Designation for Mavorixafor for the Treatment of Chronic Neutropenia by U.S. FDA

BOSTON, June 10, 2025 (GLOBE NEWSWIRE) — X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to mavorixafor, an oral CXCR4 antagonist, for the treatment of chronic neutropenia (CN). The company is currently conducting a global, pivotal Phase 3 clinical trial (4WARD) evaluating mavorixafor in certain primary CN conditions. Mavorixafor was previously granted Fast Track designation for the treatment of WHIM syndrome, a rare immunodeficiency indication for which it received FDA approval in April 2024.

“We are thrilled that the FDA has recognized the unmet needs in the chronic neutropenia community and granted us Fast Track designation for mavorixafor for the treatment of CN,” said Christophe Arbet-Engels, M.D., Ph.D., Chief Medical Officer of X4 Pharmaceuticals. “We look forward to working with the FDA and leveraging the benefits of the designation, which include more frequent communication with the agency and the potential for accelerated approval and/or priority review if certain criteria are met and maintained. With enrollment ongoing in our Phase 3 4WARD trial of mavorixafor in CN, we continue to expect full enrollment in the third or fourth quarter of this year and potential top-line data in late 2026.”

At present, the only FDA-approved treatment for CN is injectable human recombinant granulocyte-colony stimulating factor (G-CSF), approved in the 1990s for severe chronic neutropenia. G-CSF is associated with side effects that include bone pain, splenomegaly, thrombocytopenia, glomerulonephritis, vasculitis, and osteoporosis, and long-term treatment, especially at high doses, is correlated with an increased risk of leukemia in patients with congenital neutropenia. Due to these often dose-limiting toxicities and risks associated with long-term use, patients do not always receive the optimal dosage regimen on G-CSF. The company believes that oral mavorixafor has the potential to benefit those with certain primary CN conditions by offering a better balance of disease control and burden of treatment.

The FDA’s Fast Track process is designed to facilitate and streamline the development and expedite the review of drugs that have demonstrated the potential to address unmet medical needs in the treatment of a serious or life-threatening disease of condition.

About Chronic Neutropenia and Mavorixafor

Chronic neutropenia is a rare blood condition lasting more than three months and characterized by persistently or intermittently low levels of circulating neutrophils, increased risk of infections, and reduced quality of life. Neutrophils are retained in the bone marrow by the CXCR4/CXCL12 axis, creating a reserve of cells. Downregulation of the CXCR4 receptor by mavorixafor, an orally active CXCR4 antagonist, has been shown to mobilize functional neutrophils from the bone marrow into the peripheral blood across multiple disease states. The level of circulating neutrophils is typically measured by drawing blood to determine the absolute neutrophil count (ANC).

About the 4WARD Global, Pivotal Phase 3 Clinical Trial

The 4WARD trial is a global, pivotal Phase 3 clinical trial (NCT06056297) evaluating the efficacy, safety, and tolerability of oral, once-daily mavorixafor (with or without injectable granulocyte colony-stimulating factor, G-CSF) in people with congenital, acquired primary autoimmune, or idiopathic chronic neutropenia who are experiencing recurrent and/or serious infections. The 52-week trial is a randomized, double-blind, placebo-controlled, multicenter study aiming to enroll 150 participants with confirmed trough ANC levels less than 1,000 cells per microliter at baseline screening and histories of two or more serious and/or recurrent infections in the prior year. The primary endpoint of the trial is based on two outcome measures: annualized infection rate and positive ANC response.

About X4 Pharmaceuticals

X4 is delivering progress for patients by developing and commercializing innovative therapies for those with rare diseases of the immune system and significant unmet needs. Leveraging expertise in CXCR4 and immune system biology, X4 has successfully developed mavorixafor, an orally available CXCR4 antagonist that is currently being marketed in the U.S. as XOLREMDI® in its first indication. The company is also evaluating additional uses of mavorixafor and is conducting a global, pivotal Phase 3 clinical trial (4WARD) in people with certain chronic neutropenic disorders. X4 is headquartered in Boston, Massachusetts. For more information, please visit www.x4pharma.com.

X4 Forward Looking Statements

This press release contains forward-looking statements within the meaning of applicable securities laws, including the Private Securities Litigation Reform Act of 1995, as amended. These statements may be identified by the words “may,” “will,” “could,” “would,” “should,” “expect,” “plan,” “anticipate,” “intend,” “believe,” “estimate,” “predict,” “project,” “potential,” “continue,” “target,” or other similar terms or expressions that concern X4’s expectations, strategy, plans, or intentions. Forward-looking statements include, without limitation, implied or express statements regarding the initiation, timing, enrollment progress, and results of our current and future preclinical studies and clinical trials, including our ongoing pivotal Phase 3 clinical trial and the potential topline data; the timing and period during which the results of the trials will become available and reported, as well as our research and development programs; and expectations regarding the commercial potential of mavorixafor and ongoing engagement feedback from regulatory authorities, including Fast Track designation and its potential benefits, and the potential for accelerated approval and/or priority review by the FDA.

Any forward-looking statements in this press release are based on management’s current expectations and beliefs. These forward-looking statements are neither promises nor guarantees of future performance, and are subject to a variety of risks and uncertainties, many of which are beyond X4’s control, which could cause actual results to differ materially from those contemplated in these forward-looking statements, including the risks that: the expected availability, content, and timing of clinical data from X4’s ongoing clinical trials of mavorixafor may be delayed or unavailable, including the ongoing Phase 3 clinical trial and potential topline data; trials, studies and research programs may be delayed and may not have satisfactory outcomes, additionally earlier trials and studies may not be predictive of later trials and studies, including assessing the ability of mavorixafor monotherapy to durably increase absolute neutrophil count in patients with CN; the design and rate of enrollment for current clinical trials may not enable successful completion of the trial(s); X4 may be unable to obtain and maintain regulatory approvals, including meeting the Fast Track designation criteria required to be granted the potential for accelerated approval and/or priority review by the FDA; adverse safety effects may arise from the testing or use of X4’s product and product candidates; X4 may not be able to establish the potential improved balanced disease control and burden of treatment with oral mavorixafor for patients with certain primary CN conditions; and other risks and uncertainties, including those described in the section entitled “Risk Factors” in X4’s most recent Annual Report on X4’s Form 10-K , as well as in other filings X4 makes with the Securities and Exchange Commission, including its quarterly report on Form 10-Q, from time to time. X4 undertakes no obligation to update the information contained in this press release to reflect new events or circumstances, except as required by law.

X4 Investor Contact:  X4 Media Contact:
Daniel Ferry  Rhiannon Jeselonis
LifeSci Advisors Ten Bridge Communications
[email protected]  [email protected]
(617) 430-7576